1–10 of 80 results for AMD-Non-Neovascular
Modulation of Macrophages and Complement Dysfunction in Nonexudative AMD Using New Sialic Acid-Coated Nanoparticles
Carl D. Regillo, MD
Annual Meeting Talks
2023
Use of Ellipsoid Zone Analysis As an Efficacy Endpoint in Clinical Trials for Geographic Atrophy
Peter K. Kaiser, MD FASRS
Improving Vision in Dry AMD: Matching Mechanism With the Right Patient Population and Stage of Disease
Baruch D. Kuppermann, MD, PhD
The MOSAIC Study: A Clinical and Humanistic Burden of Illness Study of Patients With GA and Their Caregivers in the United States and Canada
Sophie Jane Bakri, MD
Expert Panel: Pegcetacoplan Safety
Andre J. Witkin, MD
David A. Eichenbaum, MD, FASRS
Samuel Anthony Minaker, MD, MSc
Janani Singaravelu, MS, MD
Sunir J. Garg, MD, FACS, FASRS
2024
Anatomic Changes Following a Single Injection of AVD-104 in Patients With GA Secondary to AMD in the SIGLEC Study
David S. Boyer, MD
Protective Effects of ANX007 on Central Macular Ellipsoid Zone (EZ) and Retinal Pigment Epithelium (RPE) and Association with Visual Acuity in the Phase 2 ARCHER GA Study
Glenn J. Jaffe, MD
Impact of Vitrectomy Surgery on the Progression of Age-Related Macular Degeneration
Association of Metformin Use and New-Onset of ICD-Coding of Geographic Atrophy
Dimitra Skondra, MD,PhD
Quantitative Contrast Sensitivity Longitudinal Changes Correlate Better Than Visual Acuity With Geographic Atrophy Progression
John B. Miller, MD